Iron and Lung Cancer.

Iron is an essential trace element in the human body, and its deficiency or excess induces diverse biological processes. Iron dysregulation is closely associated with the initiation and development of several malignant tumors, including lung cancer. Emerging evidence suggests a particularly important role for iron in lung cancer. Moreover, iron plays a prominent part in multiple forms of cell death, making it important for the development of potential strategies for lung cancer therapy. Here we review the function and characteristics of iron and new therapeutic opportunities in lung cancer.

• Publication year

  2019

• Venue

  Cancer Letters

• Publication date

  2019-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.canlet.2019.08.007PMID 31437477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2019

  2019cited by this paper
• Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence

  2019cited by this paper
• Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway

  2019cited by this paper
• Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified Ubiquitin Ligase.

  2018cited by this paper
• Haem iron intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

  2018cited by this paper
• The Interrelationship of Pharmacologic Ascorbate Induced Cell Death and Ferroptosis

  2018cited by this paper
• Carcinogenicity of High Consumption of Meat and Lung Cancer Risk Among Non-Smokers: A Comprehensive Meta-Analysis

  2018cited by this paper
• Iron and Cancer.

  2018cited by this paper
• Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting

  2018cited by this paper
• A meta-analysis of association between serum iron levels and lung cancer risk.

  2018cited by this paper
• Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease.

  2017cited by this paper
• NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis

  2017cited by this paper
• Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients

  2017cited by this paper
• Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

  2017cited by this paper
• Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis

  2017cited by this paper
• O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

  2017cited by this paper
• Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth

  2017cited by this paper
• IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis.

  2016cited by this paper
• Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema

  2016cited by this paper
• Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal Tumorigenesis.

  2016cited by this paper
• Dietary mineral intake and lung cancer risk: the Rotterdam Study

  2016cited by this paper
• Frailty in Pulmonary and Critical Care Medicine.

  2016cited by this paper
• Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

  2016cited by this paper
• Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth

  2016cited by this paper
• Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells.

  2016cited by this paper
• EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1.

  2016cited by this paper
• Mitochondrial iron chelation ameliorates cigarette-smoke induced bronchitis and emphysema in mice

  2015cited by this paper
• Glutaminolysis and Transferrin Regulate Ferroptosis.

  2015cited by this paper
• miR-20a regulates expression of the iron exporter ferroportin in lung cancer

  2015cited by this paper
• Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells

  2015cited by this paper
• Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis

  2014cited by this paper
• Necroptosis.

  2014cited by this paper
• Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and Function

  2014cited by this paper
• High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy

  2014cited by this paper
• Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

  2014cited by this paper
• Red and processed meat consumption and the risk of lung cancer: a dose-response meta-analysis of 33 published studies.

  2014cited by this paper
• Transferrin Receptor-Mediated Endocytosis: A Useful Target for Cancer Therapy

  2014cited by this paper
• Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence

  2013cited by this paper
• Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial

  2013cited by this paper
• Curcumin protects against iron induced neurotoxicity in primary cortical neurons by attenuating necroptosis.

  2013cited by this paper
• Lipocalin-2 is associated with radioresistance in oral cancer and lung cancer cells.

  2013cited by this paper
• Iron and cancer: more ore to be mined

  2013cited by this paper
• The Iron Chelator, Deferasirox, as a Novel Strategy for Cancer Treatment: Oral Activity Against Human Lung Tumor Xenografts and Molecular Mechanism of Action

  2013cited by this paper
• Meat consumption and risk of lung cancer: evidence from observational studies.

  2012cited by this paper
• Meat consumption and risk of lung cancer: evidence from observational studies.

  2012cited by this paper
• Ferroptosis: an iron-dependent form of nonapoptotic cell death.

  2012cited by this paper
• Necroptosis

  2012cited by this paper
• A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

  2010cited by this paper
• Cytochrome c/cardiolipin relations in mitochondria: a kiss of death.

  2009cited by this paper
• Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of Sulfasalazine for the treatment of progressing malignant gliomas in adults

  2009cited by this paper
• Linking anemia to inflammation and cancer: the crucial role of TNFalpha.

  2009cited by this paper
• A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells

  2008cited by this paper
• Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer.

  2007cited by this paper
• Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.

  2007cited by this paper
• Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.

  2006cited by this paper
• Re: Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

  2006cited by this paper
• Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

  2006cited by this paper
• Comment on: Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. Authors' reply

  2006cited by this paper
• Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion

  2006cited by this paper
• Distinct Roles of Basal Steady-State and Induced H-Ferritin in Tumor Necrosis Factor-Induced Death in L929 Cells

  2005cited by this paper
• A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake.

  2005cited by this paper
• Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

  2004cited by this paper
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

  2004cited by this paper
• Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain.

  2004cited by this paper
• Anticancer drugs: To the rescue?

  2004cited by this paper
• Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis*

  2002cited by this paper
• Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition?

  2002cited by this paper
• Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

  2000cited by this paper
• Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors.

  2000cited by this paper
• Iron-induced apoptosis in the photoreceptor cells of rats.

  1998cited by this paper
• Serum levels of interleukin 6 in patients with lung cancer.

  1995cited by this paper
• Body iron stores and risk of cancer

  1994cited by this paper
• Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice

  1991cited by this paper
• Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice.

  1988cited by this paper
• Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.

  1982cited by this paper
• Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

  1978cited by this paper

• Ferritinophagy: molecular mechanisms and its crosstalk with ferroptosis in chronic respiratory diseases

  2026cites this paper
• Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets

  2025cites this paper
• Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker

  2025influential citation
• Potentially toxic trace elemental levels in the malignant and non-malignant tissues of lungs: a comparative study by multivariate analysis from Pakistan

  2025cites this paper
• 4-octyl Itaconate Attenuates Acute Pancreatitis and Associated Lung Injury by Suppressing Ferroptosis in Mice

  2025cites this paper
• Turn-on-off sensing of thiamine and Fe3+ ions and apoptosis of A549 lung cancer cells by micro and nanorods of trimesic acid and L-ornithine linked copper/zinc bimetallic metal organic framework.

  2025cites this paper
• Hypoxia-Driven Ferroptosis Escape Mediates Lung Injury Induced by Nickel-Refining Fumes via Oxygen-Sensing Signaling PHD1/HIF-1α.

  2025cites this paper
• Targeting Cellular Energetics via Ferroptosis Mediated Cell Death in Resistant Colorectal Cancer Stem Cells

  2025cites this paper
• Carbon dots-mediated lysosomal iron sequestration for cancer immunostimulation

  2025cites this paper
• Overcoming BET‐inhibitor JQ1 resistance in aggressive non‐small cell lung cancer by inducing ferroptosis via inhibition of the BRD2–FTH1 axis

  2025cites this paper
• Nanomedicine-mediated macrophage polarization enhances the iron-depleting effect of desferrioxamine for breast cancer immunotherapy.

  2025cites this paper
• Iron(III) Complexes with Substituted Salicylaldehydes: Synthesis, Interaction with DNA and Serum Albumins, and Antioxidant Activity

  2025cites this paper
• Unveiling the therapeutic potential of ferroptosis in lung cancer: a comprehensive bibliometric analysis and future therapeutic insights

  2025cites this paper
• Emerging mechanisms of ferroptosis and its implications in lung cancer

  2024cites this paper
• Targeting Ferroptosis: A Novel Strategy for the Treatment of Atherosclerosis.

  2024cites this paper
• Associations of minerals intake with colorectal cancer risk in the prostate, lung, colorectal, ovarian cancer screening trial

  2024cites this paper
• Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in LKB1-Mutant Lung Cancer

  2024cites this paper
• Iron and cancer: overview of the evidence from population-based studies

  2024influential citation
• An "Iron-phagy" nanoparticle inducing irreversible mitochondrial damages for antitumor therapy.

  2024cites this paper
• Iron regulates MT1-MMP-mediated proMMP-2 activation and cancer cell invasion.

  2024cites this paper
• Effect of Transferrin Receptor on Autophagy of Cervical Cancer Cells

  2024cites this paper
• A ferroptosis-related signature predicts the clinical diagnosis and prognosis, and associates with the immune microenvironment of lung cancer

  2024cites this paper
• The Arabidopsis RTH plays an important role in regulation of iron (Fe) absorption and transport

  2024cites this paper
• Diagnostic and predictive significance of the ferroptosis-related gene TXNIP in lung adenocarcinoma stem cells based on multi-omics

  2024cites this paper
• The New Era of Lung Cancer Therapy: Combining Immunotherapy with Ferroptosis.

  2024cites this paper
• Ferroptosis and the ubiquitin-proteasome system: exploring treatment targets in cancer

  2024cites this paper
• A Novel Ethylenediamine Bridged Indole-BODIPY Schiff Base Applied for Selective Response to Fe, Cu and Al Detection

  2024cites this paper
• Review of mendelian randomization studies on age at natural menopause

  2023cites this paper
• Depletion of Labile Iron Induces Replication Stress and Enhances Responses to Chemoradiation in Non-Small-Cell Lung Cancer

  2023cites this paper
• Correlation between iron metabolism indicators and programmed death ligand 1 expression in advanced non-small cell lung cancer.

  2023influential citation
• Serum iron status and the risk of lung cancer: a two-sample Mendelian-randomization study

  2023cites this paper
• Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy.

  2023cites this paper
• Concentrations of Transition Metal Ions in Rat Lungs after Tobacco Smoke Exposure and Treatment with His-Leu Dipeptide

  2023cites this paper
• Adherence Does Not Guarantee the Outcome of Iron Supplementation for Reproductive-Age Women With Anemia in West Papua Province, Indonesia: A Quasi-experimental Study

  2023cites this paper
• Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules

  2023cites this paper
• Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer

  2023cites this paper
• Mechanism of Ziyuglycoside II-mediated Ferroptosis-related Proteins on the Proliferation and Metastasis of Human Lung Adenocarcinoma Cell Lines

  2023cites this paper
• Ferroptosis as a potential target for cancer therapy

  2023cites this paper
• CTRP6 protects against ferroptosis to drive lung cancer progression and metastasis by destabilizing SOCS2 and augmenting the xCT/GPX4 pathway.

  2023cites this paper
• Long non-coding RNA OGFRP1 regulates cell proliferation and ferroptosis by miR-299-3p/SLC38A1 axis in lung cancer

  2022cites this paper
• Modulations of ferroptosis in lung cancer therapy

  2022cites this paper
• Ferroptosis: A New Strategy for Cancer Therapy

  2022influential citation
• Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma

  2022cites this paper
• Solvent-free one-pot synthesis of 4-aryl-3,5-dimethyl-1,4,7,8-tetrahydrodipyrazolo[3,4-b:4′,3′-e]pyridines using Fe3O4@SiO2@(BuSO3H)3 catalytic Fe3+ system as selective colorimetric

  2022cites this paper
• Crosstalk between Heme Oxygenase-1 and Iron Metabolism in Macrophages: Implications for the Modulation of Inflammation and Immunity

  2022cites this paper
• Role of Intracellular Iron in Switching Apoptosis to Ferroptosis to Target Therapy-Resistant Cancer Stem Cells

  2022cites this paper
• Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer

  2022cites this paper
• Characterization and Toxicity Analysis of Lab-Created Respirable Coal Mine Dust from the Appalachians and Rocky Mountains Regions

  2022cites this paper
• Assessment of iron status markers in patients with lung cancer

  2022cites this paper
• Puzzling Out Iron Complications in Cancer Drug Resistance.

  2022cites this paper
• Focus on ferroptosis regulation: Exploring novel mechanisms and applications of ferroptosis regulator.

  2022cites this paper
• Role of iron biomarkers and iron intakes in lung cancer risk: A systematic review and meta-analysis.

  2022cites this paper
• New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer

  2022cites this paper
• The effect of some trace elements on the expression of telomerase gene in lung cancer.

  2022cites this paper
• Dysregulation of ferroptosis may involve in the development of non‐small‐cell lung cancer in Xuanwei area

  2021cites this paper
• The iron chelator deferoxamine decreases myeloma cell survival

  2021cites this paper
• A ferroptosis-related gene signature predicts overall survival in patients with lung adenocarcinoma.

  2021cites this paper
• The Role of Iron in Cancer Progression

  2021cites this paper
• Research progress on the occurrence and therapeutic mechanism of ferroptosis in NSCLC

  2021cites this paper
• Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy

  2021cites this paper
• Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis

  2021cites this paper
• Targeting Ferroptosis for Lung Diseases: Exploring Novel Strategies in Ferroptosis-Associated Mechanisms

  2021cites this paper
• Ferroptosis: A New Promising Target for Lung Cancer Therapy

  2021cites this paper
• Age at menopause and risk of lung cancer: A systematic review and meta-analysis.

  2021cites this paper
• Nrf2 Is a Potential Modulator for Orchestrating Iron Homeostasis and Redox Balance in Cancer Cells

  2021cites this paper
• Construction and analysis of a novel ferroptosis‐related gene signature predicting prognosis in lung adenocarcinoma

  2021cites this paper
• Properties of Some Minerals and Implications on Cancer

  2021cites this paper
• Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

  2021cites this paper
• Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities.

  2021cites this paper
• A Promising Future of Ferroptosis in Tumor Therapy

  2021cites this paper
• Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma

  2021cites this paper
• Development of a gene signature associated with iron metabolism in lung adenocarcinoma

  2021cites this paper
• Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin

  2021cites this paper
• Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease

  2021cites this paper
• The Challenges in Eradication of Iron Deficiency Anemia in Developing Countries

  2020cites this paper
• Large-Scale Transcriptome Analysis Identified Novel Ferroptosis-Related Gene Signatures for Predicting the Prognostic of Patients with Lung Adenocarcinoma

  2020cites this paper
• OTT_A_248492 10829..10840

  2020cites this paper
• Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy

  2020cites this paper
• Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis

  2020cites this paper
• Polymerized human hemoglobin increases the effectiveness of cisplatin-based chemotherapy in non-small cell lung cancer

  2020influential citation
• Mitochondrion-mediated iron accumulation promotes carcinogenesis and Warburg effect through reactive oxygen species in osteosarcoma

  2020cites this paper
• Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease

  2020cites this paper
• Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases

  2020cites this paper
• Decreased lung function is associated with elevated ferritin but not iron or transferrin saturation in 42,927 healthy Korean men: A cross-sectional study

  2020cites this paper